Neuroprotection by caffeine in the MPTP model of parkinson's disease and its dependence on adenosine A2A receptors.

Neuroscience2016Xu K, Di Luca DG, Orrú M, et al.

Study designOther primary literature

SubjectAnimal

Abstract

cc by 以外（cc by-nc / cc by-nc-nd / NONE 等）は抄録を再掲しない。DOI/PMID へのリンクのみ表示する。

MeSH

Adenosine A2 Receptor AntagonistsAnimalsAstrocytesCaffeineDopamineDopaminergic NeuronsFemaleMPTP PoisoningMaleMice, 129 StrainMice, Inbred C57BLMice, KnockoutMotor ActivityNeuroprotective AgentsProsencephalonReceptor, Adenosine A2A

DOI 10.1016/j.neuroscience.2016.02.035

PMID 26905951

View source →